Algert Global’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.03M	Sell	292,929 -141,070	-33%	-$451K	0.02%	860
2025 Q4	$1.19M	Buy	+433,999	New	+$1M	0.02%	818
2025 Q2	–	Sell	-280,882	Closed	-$935K	–	1251
2025 Q1	$935K	Buy	280,882 +224,482	+398%	+$1.16M	0.02%	779
2024 Q4	$417K	Buy	56,400 +2,330	+4%	+$21.6K	0.01%	943
2024 Q3	$508K	Buy	54,070 +18,784	+53%	+$178K	0.01%	893
2024 Q2	$283K	Sell	35,286 -3,492	-9%	-$37.4K	0.01%	1143
2024 Q1	$575K	Sell	38,778 -81,310	-68%	-$946K	0.02%	745
2023 Q4	$976K	Sell	120,088 -273,688	-70%	-$1.43M	0.04%	625
2023 Q3	$1.79M	Buy	393,776 +41,470	+12%	+$271K	0.08%	396
2023 Q2	$2.48M	Sell	352,306 -62,707	-15%	-$449K	0.11%	326
2023 Q1	$2.54M	Buy	415,013 +23,620	+6%	+$163K	0.12%	266
2022 Q4	$2.5M	Buy	391,393 +47,720	+14%	+$373K	0.14%	225
2022 Q3	$3.29M	Buy	343,673 +178,868	+109%	+$2.06M	0.2%	128
2022 Q2	$1.82M	Buy	164,805 +117,027	+245%	+$1.53M	0.14%	222
2022 Q1	$796K	Buy	47,778 +11,403	+31%	+$176K	0.05%	617
2021 Q4	$694K	Buy	36,375 +2,537	+7%	+$55.9K	0.09%	415
2021 Q3	$834K	Buy	33,838 +20,388	+152%	+$480K	0.11%	322
2021 Q2	$350K	Buy	+13,450	New	+$350K	0.12%	248
2021 Q1	–	Sell	-11,621	Closed	-$539K	–	479
2020 Q4	$539K	Buy	+11,621	New	+$461K	0.15%	213
2020 Q3	–	Sell	-30,757	Closed	-$844K	–	444
2020 Q2	$844K	Sell	30,757 -19,392	-39%	-$638K	0.29%	125
2020 Q1	$1.5M	Buy	50,149 +26,138	+109%	+$693K	0.63%	24
2019 Q4	$665K	Buy	+24,011	New	+$546K	0.2%	170
2019 Q3	–	Sell	-13,080	Closed	-$321K	–	398
2019 Q2	$321K	Buy	+13,080	New	+$197K	0.12%	215